Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Quoted Diagnostics Innovation

QUOTED. March 13, 2018. Carla Kriwet.

  • Analysis

Executive Summary

Philips has developed a contactless pulse oximetry monitoring technology that has shown promise in a small patient study. Check out what Philips Patient Care & Monitoring Solutions CEO Carla Kriwet said about it here.

"Vital-signs monitoring is crucial across all types of care settings, but for patient populations with specific conditions, managing their care in a less intrusive way is critical in order to avoid unnecessary distress. Contactless monitoring solutions will offer clinicians with a way to accurately measure vital signs for patients in a non-obtrusive way, and provide them with the data needed to know when to intervene." –Carla Kriwet, CEO, Philips Patient Care & Monitoring Solutions

Find out more: Market Intel: Medtronic, Philips, Masimo, And Others Keep Pulse Beating In Oximetry Patient Monitoring Market

Click here for a free trial of Medtech Insight

Table

View full table

Topics

Tags:
Quoted Diagnostics Innovation
Latest Headlines

News We're Watching: LDT Final Rule Near Publication, Zimmer ROSA Used In Shoulder Surgery, $60M For Menopause Clinic

Epitel Gets 510(k) Clearance On Remote EEG Technology

Valuable Health Data Sources For Medtech Industry Come A Step Closer In The EU

Rise In Class I Device Recalls A ‘Grave Concern,’ Says FDA’s Anne Reid

See All
UsernamePublicRestriction

Register

MT122327

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By